Results 121 to 130 of about 5,275 (178)

Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout. [PDF]

Ann Rheum Dis
Tedeschi SK, Hayashi K, Zhang Y, Choi H, Solomon DH.   +4 more
europepmc   +1 more source

Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation. [PDF]

Arthritis Res Ther
Holladay EE, Mudano AS, Xie F, Zhang J, Mikuls TR, LaMoreaux B, Padnick-Silver L, Curtis JR.   +7 more
europepmc   +1 more source

Urate-lowering therapy is associated with a reduced risk of arrhythmias: a systematic review and meta-analysis. [PDF]

J Rheum Dis
Waitayangkoon P, Leesutipornchai T, Techasatian W, Aiumtrakul N, Tanariyakul M, Arayangkool C, Kanthajan T, Nagamine T, Kewcharoen J.   +8 more
europepmc   +1 more source

I156 What’s New? Emerging Approaches to Urate-Lowering Therapy [PDF]

Rheumatology, 2016
openaire   +1 more source

Determinants of Achieving Serum Urate Goal with Treat-to-Target Urate-Lowering Therapy in Gout. [PDF]

Arthritis Rheumatol
Helget LN, O'Dell JR, Newcomb JA, Androsenko M, Brophy MT, Davis-Karim A, England BR, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, Wu H, Kramer B, Mikuls TR.   +13 more
europepmc   +1 more source

Erratum: Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study [Corrigendum]. [PDF]

J Inflamm Res
europepmc   +1 more source

Correction to: Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]

Rheumatology (Oxford)
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Update on emerging urate-lowering therapies

Current Opinion in Rheumatology, 2009
To discuss currently available urate-lowering therapeutic options for gout in the United States and newer therapeutic initiatives in development.Currently available urate-lowering drugs include allopurinol and probenecid. These drugs are effective but are often underdosed or underutilized, and caution must be taken in patients with multiple ...
Saima, Chohan, Michael A, Becker
openaire   +2 more sources